- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Glucose Regulation in Belgium
Total 316 results
-
Dompé Farmaceutici S.p.ATerminatedNew-onset Type 1 DiabetesUnited States, Belgium, Georgia, Germany, Italy, Serbia
-
Robert LodderUniversity of KentuckyCompletedType 2 DiabetesUnited States, India
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesIndia
-
Imcyse SACompletedType 1 Diabetes MellitusUnited Kingdom, Belgium, Denmark, Germany, Lithuania, Sweden, France
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Belgium, United Kingdom, Slovenia
-
SanofiCompletedDiabetes Mellitus, Type 2France, Korea, Republic of, Russian Federation, Spain, Italy, Belgium, Germany, Hungary, Ireland, Mexico, Poland, Taiwan, Turkey, Netherlands, Greece, Lithuania, Sweden, United Kingdom
-
Medical University of GrazJuvenile Diabetes Research FoundationRecruitingDiabetes Mellitus, Type 1United Kingdom, Belgium, Poland, Austria, France, Germany, Italy
-
ViaCyteCalifornia Institute for Regenerative Medicine (CIRM); Horizon 2020 - European...CompletedType 1 Diabetes Mellitus With HypoglycemiaUnited States, Canada, Belgium
-
Poitiers University HospitalHospices Civils de Lyon; Centre Hospitalier Universitaire Dijon; University Hospital... and other collaboratorsRecruitingDiabetic Kidney Disease | Type2 DiabetesFrance, Belgium
-
Novo Nordisk A/SEnrolling by invitationDiabetes Mellitus, Type 1Belgium, France, Denmark, Sweden
-
Precigen Actobio T1D, LLCTFS Trial Form Support; Intrexon Actobiotics NV, d/b/a Precigen ActobioCompleted
-
EUROSPK Study GroupWyeth is now a wholly owned subsidiary of Pfizer; Hoffmann-La Roche; Genzyme,... and other collaboratorsCompletedDiabetes Mellitus, Type 1 | Diabetic NephropathyBelgium, Israel, Germany, Austria, Czechia, Spain, Switzerland
-
Novartis PharmaceuticalsCompletedType 1 Diabetes MellitusBelgium, Italy, Spain, United Kingdom, Germany, Slovenia
-
Novartis PharmaceuticalsCompletedDiabetes Mellitus, Type 2Austria, Argentina, Australia, Belgium, Brazil, Canada, Chile, China, Colombia, Denmark, Ecuador, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Italy, Malaysia, Mexico, Netherlands, Norway, Peru, Poland, Russian Federation and more
-
Imcyse SATerminatedDiabetes Mellitus, Type 1United Kingdom, United States, Australia, Lithuania, Belgium, Italy, Slovenia, Sweden
-
SanofiCompletedDiabetes Mellitus, Type 1Belgium, France, Netherlands, Sweden
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Israel, Korea, Republic of, Turkey, Italy, Belgium, United Kingdom, Greece, Ireland, Sweden, Denmark, Finland, France, Czech Republic
-
Medtronic DiabetesCompletedDiabetes Mellitus, Type 1Denmark, Spain, Belgium, Serbia, Sweden, Austria, France, Hungary, Israel, Italy, Lithuania, Poland, Slovakia, Slovenia
-
ITB-Med LLCRecruitingDiabetes Mellitus, Type 1Belgium, Spain, United Kingdom, Italy, Germany, Poland, France, Sweden
-
University of CambridgeJuvenile Diabetes Research Foundation; The Leona M. and Harry B. Helmsley Charitable... and other collaboratorsUnknownType 1 Diabetes MellitusAustria, Italy, Finland, Denmark, Germany, Belgium, United Kingdom, France, Luxembourg, Norway, Poland, Slovenia, Sweden
-
Solvay PharmaceuticalsCompletedHyperlipidemia CombinedBelgium, France, Germany
-
NovartisCompletedType 2 Diabetes MellitusGermany, Romania, Hungary, Belgium, Slovakia, Australia, India, Czech Republic, Guatemala, Hong Kong, United Kingdom
-
Bristol-Myers SquibbOtsuka America PharmaceuticalTerminatedSchizophrenia | Metabolic SyndromeFrance, Hungary, Spain, Czech Republic, Belgium, Germany, Greece, Switzerland, Turkey
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesPoland, Russian Federation, Denmark, Sweden, Macedonia, The Former Yugoslav Republic of, Norway, Croatia, France, Belgium, Slovakia
-
Eli Lilly and CompanyCompletedA Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes PatientsDiabetes Mellitus, Type 2Romania, Italy, Belgium, Poland, Greece, Germany, United Kingdom, Turkey, Czech Republic, Slovakia
-
Novo Nordisk A/SCompletedDiabetes | Diabetes Mellitus, Type 1Germany, France, Denmark, Sweden, Netherlands, Belgium, Finland, Macedonia, The Former Yugoslav Republic of, Norway, Israel, Spain, Croatia, Slovenia, United Kingdom, Switzerland, Ireland
-
AstraZenecaTerminatedType 2 DiabetesItaly, Poland, South Africa, Malaysia, Hungary, Belgium, Slovakia, Philippines, Thailand, Hong Kong
-
Novartis PharmaceuticalsCompletedType 2 Diabetes MellitusUnited Kingdom, Belgium, Bulgaria, Spain, Slovakia, Germany, Finland
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2United States, Belgium, Canada, China, Germany, India, Ireland, Japan, Switzerland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited Kingdom, Poland, Spain, India, Argentina, China
-
Robert LodderUniversity of KentuckyCompleted
-
PfizerTerminatedDiabetes Mellitus, Type 1Denmark, Spain, Sweden, United States, Belgium, Austria, France, Portugal, Ireland, United Kingdom, Finland, Netherlands, Norway
-
Assistance Publique - Hôpitaux de ParisIltoo PharmaCompletedType 1 DiabetesBelgium, France, Germany, Netherlands, Sweden, Switzerland
-
Boehringer IngelheimEli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Bangladesh, Belgium, Canada, China, Germany, Guatemala, Hong Kong, India, Lebanon, Mexico, Peru, Philippines, Spain, Taiwan
-
Eli Lilly and CompanyActive, not recruitingType 2 DiabetesUnited States, Belgium, Germany, Mexico, Romania
-
Johnson & Johnson Pharmaceutical Research & Development...CompletedDiabetes Mellitus, Type 2 | Diabetes Mellitus | Endocrine System Diseases | Nutritional and Metabolic DiseasesUnited Kingdom, Germany, Belgium, Poland, India, Finland, Sweden, Netherlands, Russian Federation, Norway, Denmark
-
Lexicon PharmaceuticalsSanofiCompletedType 1 Diabetes Mellitus (T1DM) | High Level of Sugar (Glucose) in the BloodUnited States, Australia, Spain, Belgium, Argentina, Bulgaria, Canada, Colombia, Czechia, France, Germany, Hungary, Israel, Italy, New Zealand, Poland, Slovakia, South Africa, United Kingdom
-
AstraZenecaTerminatedType 2 DiabetesItaly, Poland, South Africa, Norway, Belgium, Hungary, Slovakia, Taiwan, Philippines, Thailand, Mexico, Hong Kong, Malaysia
-
SanofiRecruitingType 1 Diabetes MellitusBelgium, Spain, Canada, United States, Poland, France, Sweden, Denmark, Germany, Italy, United Kingdom, Hungary
-
Eli Lilly and CompanyBoehringer IngelheimCompletedDiabetes Mellitus, Type 1Japan, United States, Greece, Belgium, Poland, Germany, Hungary, Mexico, Romania
-
AstraZenecaBristol-Myers SquibbCompletedType 2 Diabetes MellitusFrance, Italy, Turkey, Germany, United Kingdom, Belgium, Spain
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Argentina, Belgium, Canada, China, Germany, Korea, Republic of, Philippines, Russian Federation, Taiwan, Turkey, United Kingdom
-
Provention Bio, a Sanofi CompanyActive, not recruitingDiabetes Mellitus, Type 1United States, Belgium, Canada, Czechia, France, Germany, Poland, United Kingdom
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Austria, Belgium, Norway, Turkey, Switzerland, Argentina, Korea, Republic of, Brazil, Egypt
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Croatia, France, Sweden, Poland, Turkey, Korea, Republic of, India, South Africa
-
Janssen Research & Development, LLCCompletedDiabetes Mellitus, Type 2United States, United Kingdom, Belgium, Spain, Israel, Mexico, Australia, Russian Federation, Hungary, France, Guatemala, Puerto Rico
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Argentina, India, Australia, Spain, Taiwan, France, Canada, Hungary, Mexico, Croatia, Korea, Republic of, Poland, Greece, Belgium, Brazil, Italy, Czech Republic, Romania, Slovakia, Sweden
-
Boehringer IngelheimCompletedDiabetes Mellitus, Type 2Belgium, Canada, France, India, Italy, Korea, Republic of, Malaysia, Netherlands, Spain
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2United States, Mexico, Netherlands, Russian Federation, India, Belgium, Japan, Romania, Italy
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesUnited States, Germany, United Kingdom, Austria, Belgium, France, Ireland